Edition:
United Kingdom

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

65.05EUR
23 Feb 2018
Change (% chg)

€0.16 (+0.25%)
Prev Close
€64.89
Open
€65.01
Day's High
€65.22
Day's Low
€64.42
Volume
1,434,698
Avg. Vol
2,518,356
52-wk High
€92.97
52-wk Low
€63.09

Select another date:

Fri, Feb 16 2018

BRIEF-Ablynx Announces Option Exercise By Sanofi To License Two Additional Target Combinations​

* ABLYNX ANNOUNCES OPTION EXERCISE BY SANOFI FOR TWO ADDITIONAL MULTI-SPECIFIC NANOBODY PRODUCT CANDIDATES

Oxford BioMedica wins second $100 million gene therapy contract

LONDON Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $11.6 billion.

Oxford BioMedica wins second $100 million gene therapy contract

LONDON Britain's Oxford BioMedica has won a second $100 million (£71.2 million) contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $11.6 billion.

Oxford BioMedica wins second $100 mln gene therapy contract

LONDON, Feb 15 Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $11.6 billion.

L'Oreal ready to buy Nestle stake in cosmetics leader

PARIS L'Oreal on Friday underscored its readiness to buy Nestle's 23 percent stake in the world's biggest cosmetics firm were its Swiss shareholder to sell, saying it had access to cash and funding at its disposal.

L'Oreal ready to buy Nestle stake in cosmetics leader

PARIS L'Oreal on Friday underscored its readiness to buy Nestle's 23 percent stake in the world's biggest cosmetics firm were its Swiss shareholder to sell, saying it had access to cash and funding at its disposal.

L'Oreal ready to buy shareholder Nestle's stake in the firm: CEO

PARIS L'Oreal stands ready to buy Nestle's 23 percent stake in the firm should its Swiss shareholder choose to sell, and it could finance a purchase through cash, by selling its Sanofi stake or by borrowing, L'Oreal's CEO said.

L'Oreal ready to buy shareholder Nestle's stake in the firm - CEO

PARIS L'Oreal stands ready to buy Nestle's 23 percent stake in the firm should its Swiss shareholder choose to sell, and it could finance a purchase through cash, by selling its Sanofi stake or by borrowing, L'Oreal's CEO said.

L'Oreal ready to buy shareholder Nestle's stake in the firm - CEO

PARIS, Feb 9 L'Oreal stands ready to buy Nestle's 23 percent stake in the firm should its Swiss shareholder choose to sell, and it could finance a purchase through cash, by selling its Sanofi stake or by borrowing, L'Oreal's CEO said.

BRIEF-Sanofi Commences Tender Offer For Acquisition Of Bioverativ

* SANOFI COMMENCES TENDER OFFER FOR ACQUISITION OF BIOVERATIV INC.

Select another date: